Increase in CTL Precursor Frequency After Adoptive Transfer of EBV-Specific CTL
| UPN . | Before CTL Infusion . | 1 Mo After Infusion . |
|---|---|---|
| 282 | 1/285,176 | 1/7,860 |
| 293 | 1/31,250 | 1/975 |
| 296 | <1/500,000 | 1/975 |
| 314 | <1/500,000 | 1/15,700 |
| 317 | 1/25,000 | 1/1,952 |
| 324 | <1/500,000 | 1/3,905 |
| 337 | 1/145,833 | 1/3,905 |
| 345 | 1/3,900 | 1/1,952 |
| 347 | 1/207,622 | 1/1,560 |
| 401 | 1/107,638 | 1/31,300 |
| 414 | 1/604,525 | 1/32,005 |
| 419 | 1/207,622 | 1/71,905 |
| UPN . | Before CTL Infusion . | 1 Mo After Infusion . |
|---|---|---|
| 282 | 1/285,176 | 1/7,860 |
| 293 | 1/31,250 | 1/975 |
| 296 | <1/500,000 | 1/975 |
| 314 | <1/500,000 | 1/15,700 |
| 317 | 1/25,000 | 1/1,952 |
| 324 | <1/500,000 | 1/3,905 |
| 337 | 1/145,833 | 1/3,905 |
| 345 | 1/3,900 | 1/1,952 |
| 347 | 1/207,622 | 1/1,560 |
| 401 | 1/107,638 | 1/31,300 |
| 414 | 1/604,525 | 1/32,005 |
| 419 | 1/207,622 | 1/71,905 |
CTL precursor frequency was calculated as described previously22 and in Patients and Methods.